Home › Companies › DYNE THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and DYNE THERAPEUTICS INC.’s Form 8-K, filed 2025-06-05 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Proxy season: 2024-2025 2025-2026
Explore DYNE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DYNE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Edward Hurwitz | 62,904,718 | -- | -- | 27,406,392 | 15,360,066 | Majority: yes |
| Elect Director: Dirk Kersten | 58,322,540 | -- | -- | 31,988,570 | 15,360,066 | Majority: yes |
| b) The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers. | 74,412,453 | 15,817,102 | 81,555 | -- | 15,360,066 | Majority: yes |
| c) The stockholders of the Company recommended, on a non-binding advisory basis, that future advisory votes on the compensation of the Company's named executive officers be held every year. | 105,567,007 | 19,843 | 84,326 | -- | -- | Majority: yes |
Source: DYNE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-05 — read the filing on EDGAR.
Each item below shows how the 194 asset managers that disclosed a DYNE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DYNE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
DYNE THERAPEUTICS INC.’s own tally for this item (“b) The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”): 74,412,453 for, 15,817,102 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,633,782 outstanding shares: 65% for, 14% against (79% of the company cast a for/against vote).
The 189 asset managers below cast 81% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,312,756 | 27,205 | 0 | 0 | For |
| Janus Henderson | 9,487,781 | 0 | 0 | 0 | For |
| Vanguard | 7,469,063 | 464,984 | 0 | 0 | For |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 5,579,200 | 0 | 0 | 0 | For |
| FCPM III SERVICES B.V. | 5,462,846 | 0 | 0 | 0 | For |
| BlackRock | 997,971 | 4,460,194 | 0 | 0 | Against |
| State Street | 46,337 | 5,172,805 | 0 | 0 | Against |
| T. Rowe Price | 5,196,080 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 2,912,641 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,717,987 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 2,650,150 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,620,576 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 2,567,610 | 0 | 0 | 0 | For |
| Citadel | 2,478,913 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 2,173,913 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 2,000,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,957,900 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 1,908,533 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,640,030 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,405,840 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 51,899 | 1,300,871 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,306,700 | 0 | 0 | Against |
| Vestal Point Capital, LP | 1,183,937 | 0 | 0 | 0 | For |
| JPMorgan | 1,130,679 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 1,114,960 | 0 | 0 | 0 | For |
Showing the 25 largest of 189 asset managers. See all 189 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% fund support · no official result
The 185 asset managers below cast 99.9% of the shares they voted on this item FOR (10,386,716 for, 532 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | One Year |
| Janus Henderson | 0 | 0 | 0 | 0 | One Year |
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0 | 0 | 0 | 0 | One Year |
| FCPM III SERVICES B.V. | 5,462,846 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 0 | 1 Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| T. Rowe Price | 0 | 0 | 0 | 0 | One Year |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | One Year |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | 1 Year |
| TCG Crossover Management, LLC | 2,650,150 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 0 | One Year |
| ARMISTICE CAPITAL, LLC | 0 | 0 | 0 | 0 | 1 Year |
| Citadel | 0 | 0 | 0 | 0 | One Year |
| VR Adviser, LLC | 0 | 0 | 0 | 0 | One Year |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | 1 Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| PERCEPTIVE ADVISORS LLC | 1,908,533 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | One Year |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | One Year |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | One Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | One Year |
| JPMorgan | 0 | 0 | 0 | 0 | 1 Year |
| Vivo Capital, LLC | 0 | 0 | 0 | 0 | One Year |
Showing the 25 largest of 185 asset managers. See all 185 in the interactive database.
Combines 3 wordings of this item as funds reported it.
65% Majority: yes · of votes cast
DYNE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dirk Kersten”): 58,322,540 for, 31,988,570 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,633,782 outstanding shares: 51.3% for, 28% withheld (79% of the company cast a for/withheld vote).
The 56 asset managers below cast 100% of the shares they voted on this item FOR (18,702,356 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,703,864 | 0 | 0 | 0 | For |
| Fidelity | 5,093,824 | 0 | 51,651 | 0 | For |
| BlackRock | 0 | 0 | 3,301,280 | 0 | Abstain |
| JANUS INVESTMENT FUND | 0 | 0 | 2,620,576 | 0 | Abstain |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 4,494 | 0 | 1,826,857 | 0 | Abstain |
| JPMorgan | 1,105,879 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 772,518 | 0 | 0 | 0 | For |
| Charles Schwab | 653,350 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 314,586 | 0 | Abstain |
| Equitable | 0 | 0 | 228,251 | 0 | Abstain |
| TIAA | 0 | 0 | 218,559 | 0 | Abstain |
| Exchange Place Advisors Trust | 203,520 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 190,914 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 152,859 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 139,245 | 0 | Abstain |
| MERIDIAN FUND INC | 113,936 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 113,799 | 0 | Abstain |
| Brighthouse | 45,200 | 0 | 42,602 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 54,511 | 0 | Abstain |
| ProShares | 0 | 0 | 53,012 | 0 | Abstain |
| Global X | 49,606 | 0 | 0 | 0 | For |
| MoA Funds Corp | 0 | 0 | 48,516 | 0 | Abstain |
| Northern Trust | 0 | 0 | 44,120 | 0 | Abstain |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 3 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
DYNE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Edward Hurwitz”): 62,904,718 for, 27,406,392 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,633,782 outstanding shares: 55% for, 24% withheld (79% of the company cast a for/withheld vote).
The 56 asset managers below cast 100% of the shares they voted on this item FOR (21,598,580 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,703,864 | 0 | 0 | 0 | For |
| Fidelity | 5,121,029 | 0 | 24,446 | 0 | For |
| BlackRock | 2,568,951 | 0 | 732,329 | 0 | For |
| JANUS INVESTMENT FUND | 0 | 0 | 2,620,576 | 0 | Abstain |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 4,494 | 0 | 1,826,857 | 0 | Abstain |
| JPMorgan | 1,105,879 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 772,518 | 0 | 0 | 0 | For |
| Charles Schwab | 653,350 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 314,586 | 0 | Abstain |
| Equitable | 131,611 | 0 | 96,640 | 0 | For |
| TIAA | 0 | 0 | 218,559 | 0 | Abstain |
| Exchange Place Advisors Trust | 203,520 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 190,914 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 152,859 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 139,245 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 113,936 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 113,799 | 0 | Abstain |
| Brighthouse | 45,200 | 0 | 42,602 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 54,511 | 0 | Abstain |
| ProShares | 0 | 0 | 53,012 | 0 | Abstain |
| Global X | 49,606 | 0 | 0 | 0 | For |
| MoA Funds Corp | 0 | 0 | 48,516 | 0 | Abstain |
| Northern Trust | 0 | 0 | 44,120 | 0 | Abstain |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
99.9% fund support · no official result
The 56 asset managers below cast 99.9% of the shares they voted on this item FOR (28,154,653 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,703,864 | 0 | 0 | 0 | For |
| Fidelity | 5,145,475 | 0 | 0 | 0 | For |
| BlackRock | 3,301,280 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,620,576 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 1,831,351 | 0 | 0 | 0 | For |
| JPMorgan | 1,105,879 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 772,518 | 0 | 0 | 0 | For |
| Charles Schwab | 653,350 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 314,586 | 0 | 0 | 0 | For |
| Equitable | 228,251 | 0 | 0 | 0 | For |
| TIAA | 218,559 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 203,520 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 190,914 | 0 | 0 | 0 | For |
| Victory Capital | 152,859 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 139,245 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 113,936 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,799 | 0 | 0 | 0 | For |
| Brighthouse | 74,864 | 0 | 12,938 | 0 | For |
| Direxion Shares ETF Trust | 54,511 | 0 | 0 | 0 | For |
| ProShares | 53,012 | 0 | 0 | 0 | For |
| Global X | 49,606 | 0 | 0 | 0 | For |
| MoA Funds Corp | 48,516 | 0 | 0 | 0 | For |
| Northern Trust | 44,120 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
88% fund support · no official result
The 3 asset managers below cast 88% of the shares they voted on this item FOR (1,742,103 for, 228,261 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 1,742,070 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 0 | 228,261 | 0 | 0 | Against |
| Coyle Financial Counsel LLC | 33 | 0 | 0 | 0 | For |
— fund support · no official result
No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 0 | 0 | 0 | 0 | One Year |
| Coyle Financial Counsel LLC | 0 | 0 | 0 | 0 | 1 Year |
Ranked by the number of DYNE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 113,633,782 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 9.10% |
| 2 | Janus Henderson | 8.35% |
| 3 | Vanguard | 6.98% |
| 4 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 4.91% |
| 5 | FCPM III SERVICES B.V. | 4.81% |
| 6 | BlackRock | 4.80% |
| 7 | State Street | 4.59% |
| 8 | T. Rowe Price | 4.57% |
| 9 | RA CAPITAL MANAGEMENT, L.P. | 2.56% |
| 10 | Siren, L.L.C. | 2.39% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 12.01% | 13G |
| BlackRock | 7.08% | 13F |
| Vanguard Group | 6.52% | 13F |
| Atlas Venture Fund XI, L.P. | 5.01% | 13G |
| ForDyne B.V. | 4.75% | 13G |
| FMR (Fidelity) | 4.57% | 13F |
| State Street | 3.18% | 13F |
| Citadel Advisors | 2.70% | 13F |
| JPMorgan Chase | 2.23% | 13F |
| Geode Capital | 1.72% | 13F |
Percentages above are of 113,633,782 shares outstanding, as reported by DYNE THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DYNE THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At DYNE THERAPEUTICS INC.'s shareholder meeting held 2025-05-30, in the 2024-2025 proxy season, 194 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,479 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO VOTE, ON AN ADVISORY BASIS, TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — FOR was 82% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: DYNE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-05.
DYNE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.